Skip to search formSkip to main contentSkip to account menu

butalamine

Known as: N,N-dibutyl-N'-(3-phenyl-1,2,4-oxadiazol-5-yl)-1,2-ethanediamine 
National Institutes of Health

Related topics

Related topics

6 relations

Narrower (4)

AdrevilBUTALAMINE HCLLA 1221Surheme

Broader (2)

OxadiazolesVasodilator Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
[Prolonged treatment of obliterantive arteritis with butalamine. Follow up study of 42 cases during more than 1 year of rheographic control].
1978
1978
[Pharmacotherapy of peripheral arteriosclerosis].
Peripheral atherosclerosis was treated in 178 patients: 90 were given pyridinol carbamate for 2--4 months, 40 pentoxyphylline, 30… 
1978
1978
2573 – BUTALAMINE VERSUS PLACEBO IN A DOUBLE BLIND INVESTIGATION OF GERIATRIC MEMORY
1976
1976
Effects of butalamine on oxydative phosphorylations in the rat liver.
The effect of 3-phenyl-4-dibutylaminoethyl-5-inimino-1,2,4-oxadiazole (butalamine) was investigated in vivo and in vitro on… 
1976
1976
[Surheme (Butalamine) in the treatment of vertigo].
  • K. Zmigrodzka
  • Otolaryngologia polska = The Polish…
  • 1976
  • Corpus ID: 8067534
1976
1976
[Test of butalamine in labyrinth diseases].
  • A. Morgon
  • JFORL. Journal francais d'oto-rhino-laryngologie…
  • 1976
  • Corpus ID: 20994059
1973
1973
[Clinical trial of butalamine].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)